Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kyle Lefkoff currently holds 70,000 shares of ARRAY BIOPHARMA INC (ARRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Lefkoff has been a net seller of ARRY stock. They have purchased $62.7K and sold $5.2M worth of shares.
Kyle Lefkoff's most recent insider trade was on Jul 30, 2019, when they sold 85 shares at $48.00 per share.
Kyle Lefkoff serves as Executive at ARRAY BIOPHARMA INC (ARRY). They have executed 72 insider transactions totaling $5.3M over their tenure at the company.
Kyle Lefkoff holds the position of Executive at ARRAY BIOPHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Kyle Lefkoff has shown a selling trading pattern, with $62.7K in total purchases and $5.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kyle Lefkoff was on Jul 30, 2019, when they sold $1.4M worth of ARRY shares. This transaction involved 30,000 shares at $48.00 per share.
Kyle Lefkoff currently owns 70,000 shares of ARRAY BIOPHARMA INC (ARRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kyle Lefkoff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kyle Lefkoff has 72 Form 4 filings on record as an insider at ARRAY BIOPHARMA INC.
Set alerts for Kyle Lefkoff and 40,000+ other insiders.